Turn Therapeutics

TTRXNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$456.949 M

$15.34 +2.68%

Close of 21 Sept 2026

Revenue

—

Not reported

Earnings

-$3.19M

Loss-making

Shares outstanding

29,788,040

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#207KamadaKMDA$504.4M
#208Puma BiotechnologyPBYI$495.0M
#209Turn TherapeuticsTTRX$456.9M
#210Relmada TherapeuticsRLMD$443.7M
#211VogenxVOGX$438.2M

What if Turn Therapeutics were worth as much as…

Open the what-if tool →

Gold $30.3T

$1,016,316

Per share 66,253× higher

Bitcoin $1.72T

$57,734.71

Per share 3,764× higher

Nvidia $5.48T

$183,961.68

Per share 11,992× higher

Or at a round number

$1.00B $2.00B $5.00B $10.0B

Where these numbers come from

Share counts and financials for Turn Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.